Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
GlobeStar Therapeutics Corporation ("GlobeStar"), headquartered in Richland, Washington, was incorporated in 2016 and owns breakthrough addition of treatment for Multiple Sclerosis and other neurodegenerative diseases as well other pharmaceuticals and nutraceutical. GlobeStar is a clinical stage pha... GlobeStar Therapeutics Corporation ("GlobeStar"), headquartered in Richland, Washington, was incorporated in 2016 and owns breakthrough addition of treatment for Multiple Sclerosis and other neurodegenerative diseases as well other pharmaceuticals and nutraceutical. GlobeStar is a clinical stage pharmaceutical company testing a worldwide patented formulation of 3 drugs previously approved by the FDA. Pre-clinical trials in Italy showed the drug combination was effective in the reduction of MS co-morbidities. GlobeStar is initiating discussions with the FDA on clinical trial design in the U.S. in preparation for FDA submission and approval. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0001 | 50 | 0.0002 | 0.0003 | 0.0002 | 2716679 | 0.0003 | CS |
| 4 | 0 | 0 | 0.0003 | 0.0003 | 0.0001 | 3265126 | 0.00029417 | CS |
| 12 | -0.0001 | -25 | 0.0004 | 0.0004 | 0.0001 | 3822999 | 0.00030165 | CS |
| 26 | -0.0002 | -40 | 0.0005 | 0.0007 | 0.0001 | 8266475 | 0.00038581 | CS |
| 52 | -0.0017 | -85 | 0.002 | 0.0025 | 0.0001 | 7931652 | 0.00055169 | CS |
| 156 | -0.00645 | -95.5555555556 | 0.00675 | 0.0241 | 0.0001 | 6507112 | 0.0033175 | CS |
| 260 | -0.0202 | -98.5365853659 | 0.0205 | 0.073 | 0.0001 | 5631835 | 0.00470625 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
